Anti-Human IL17A Therapeutic Antibody (ANB004)

Recombinant Human monoclonal antibody expressed in CHO binding to Human IL17A. ANB004 is a novel anti-IL17 monoclonal antibody used for the treatment of autoimmune and inflammatory conditions. Recent clinical data has validated the therapeutic benefit of IL17 blockade in treatment of a number of autoimmune and inflammatory diseases, notably psoriasis, rheumatoid arthritis and uveitis.
Supplier Creative Biolabs
Product # TAB-399CL
Pricing Inquiry
Host Human
Target IL17A
Species Reactivity Human
Type Antibody
Storage Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples.
Feedback